Head and Neck Neoplasms: all 2,403 studies

Page 24 of 25. Open to participants first (559), then studies with results posted, then the rest; newest registration first within each.

• Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerCompletedNCT00024089Phase 2
• Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerCompletedNCT00023959Phase 1
• Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck CancerCompletedNCT00022594Phase 2
• Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck CancerStatus unknownNCT00022373Phase 3
• Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck CancerStatus unknownNCT00022217Phase 2
• Vaccine Therapy in Treating Patients With Stage IV Head and Neck CancerCompletedNCT00021424Phase 1
• Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung CancerCompletedNCT00021333Phase 2
• Radiation Therapy in Treating Patients With Head and Neck CancerCompletedNCT00021125Phase 3
• Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorCompletedNCT00021047Phase 1/2
• Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00020189Phase 2
• Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsCompletedNCT00019331Phase 2
• Vaccine Therapy in Treating Patients With Advanced or Recurrent CancerCompletedNCT00019110Phase 1
• Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck CancerCompletedNCT00017511Phase 3
• Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck CancerTerminatedNCT00017277Phase 3
• S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or ThroatTerminatedNCT00017173Phase 2
• ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and NeckCompletedNCT00015964Phase 2
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid TumorsCompletedNCT00014456Phase 1
• Celecoxib in Treating Patients With Precancerous Lesions of the MouthCompletedNCT00014404Phase 2
• Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or ThroatCompletedNCT00012168Not applicable
• Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck CancerCompletedNCT00011999Phase 2
• Patient Evaluation for Head and Neck Surgery Branch StudiesTerminatedNCT00011492
• Gene Therapy in Treating Patients With Advanced Head and Neck CancerCompletedNCT00009841Phase 1
• Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck CancerCompletedNCT00008398Phase 3
• S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or ThroatTerminatedNCT00006994Phase 3
• Immunotoxin Therapy in Treating Patients With Advanced CancerCompletedNCT00006981Phase 1
• Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck CancerCompletedNCT00006799Phase 3
• Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck CancerCompletedNCT00006481Phase 3
• Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00006471Phase 2
• SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and NeckCompletedNCT00006361Phase 2
• Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth CancerCompletedNCT00006341Phase 2
• S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck CancerCompletedNCT00006248Phase 2
• Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00006107Phase 1
• ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck CancerWithdrawnNCT00006106Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck CancerCompletedNCT00006051Phase 2
• Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT00006036Phase 1
• Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck CancerCompletedNCT00006033Phase 2
• Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck CancerCompletedNCT00005814Phase 2
• SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and NeckCompletedNCT00005647Phase 1
• Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck CancerCompletedNCT00005088Phase 2
• Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck CancerCompletedNCT00005087Phase 2
• Oxaliplatin in Treating Patients With Advanced Head and Neck CancerCompletedNCT00005035Phase 2
• Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck CancerCompletedNCT00004917Phase 3
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth CancerCompletedNCT00004901Phase 1/2
• Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin ChemotherapyCompletedNCT00004865Phase 2
• EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue SarcomaTerminatedNCT00004261Phase 1
• Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or LarynxCompletedNCT00004246Phase 1
• Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or LarynxTerminatedNCT00004227Phase 3
• Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation TherapyStatus unknownNCT00004226Phase 1/2
• Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the NasopharynxStatus unknownNCT00004164Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck CancerStatus unknownNCT00004097Phase 1
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or LarynxStatus unknownNCT00004094Phase 2
• Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck CancerCompletedNCT00004070Phase 1/2
• Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerCompletedNCT00004065Phase 1
• S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck CancerCompletedNCT00003908Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerCompletedNCT00003888Phase 3
• Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation TherapyStatus unknownNCT00003856Phase 2
• Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00003850Phase 2
• Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck CancerCompletedNCT00003809Phase 3
• Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck CancerTerminatedNCT00003777Phase 2
• High-dose ICE With AmifostineCompletedNCT00003657Phase 2
• Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the NasopharynxStatus unknownNCT00003637Phase 3
• Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck CancerCompletedNCT00003592Phase 3
• Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck CancerCompletedNCT00003582Phase 1/2
• Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck CancerCompletedNCT00003580Phase 2
• Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During SurgeryCompletedNCT00003576Phase 3
• Docetaxel in Treating Patients With Solid TumorsCompletedNCT00003565Phase 2
• Antineoplaston Therapy in Treating Patients With Advanced Head and Neck CancerTerminatedNCT00003489Phase 2
• Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck CancerCompletedNCT00003443Phase 2
• L-778,123 in Treating Patients With Recurrent or Refractory Solid TumorsCompletedNCT00003430Phase 1
• Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00003328Phase 3
• Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck CancerStatus unknownNCT00003327Phase 2
• Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck CancerCompletedNCT00003264Phase 2
• Gene Therapy in Treating Patients With Recurrent Head and Neck CancerStatus unknownNCT00003257Phase 2
• Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck CancerStatus unknownNCT00003251Phase 1/2
• SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the MouthTerminatedNCT00003223Phase 2
• Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and NeckCompletedNCT00003200Phase 1
• Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00003193Phase 1/2
• Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and NeckStatus unknownNCT00003182Phase 1/2
• Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck CancerCompletedNCT00003139Phase 3
• Chemotherapy in Treating Patients With Solid TumorsCompletedNCT00003103Phase 1/2
• S9709, Laser Surgery Plus Radiation Therapy in Treating Patients With Early Stage Cancer of the LarynxTerminatedNCT00003040Phase 2
• S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the NasopharynxWithdrawnNCT00002999Phase 2
• Porfimer Sodium in Diagnosing Patients With Head and Neck CancerCompletedNCT00002964Phase 2
• Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck CancerCompletedNCT00002951Phase 2
• Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and NeckCompletedNCT00002932Phase 2
• Paclitaxel in Treating Patients With Advanced Head and Neck CancerCompletedNCT00002922Phase 2
• Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver FunctionCompletedNCT00002901Phase 1
• Combination Chemotherapy in Treating Patients With Advanced Head and Neck CancerCompletedNCT00002888Phase 3
• Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00002774Phase 2
• Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth CancerStatus unknownNCT00002747Phase 3
• Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal CordCompletedNCT00002727Phase 3
• Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or OropharynxStatus unknownNCT00002702Phase 3
• Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and NeckCompletedNCT00002695
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During SurgeryCompletedNCT00002670Phase 3
• Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck CancerStatus unknownNCT00002659Phase 3
• Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck CancerCompletedNCT00002654Phase 3
• High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck CancerCompletedNCT00002555Phase 3
• Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck CancerCompletedNCT00002533Phase 2/3
• Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck CancerCompletedNCT00002507Phase 3
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the LarynxCompletedNCT00002496Phase 3

← Head and Neck Neoplasms overview